0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sacral Neuromodulation Device Market Research Report 2025
Published Date: 2025-12-08
|
Report Code: QYRE-Auto-37Q11852
Home | Market Reports
Global Sacral Neuromodulation Device Market Research Report 2022
BUY CHAPTERS

Global Sacral Neuromodulation Device Market Research Report 2025

Code: QYRE-Auto-37Q11852
Report
2025-12-08
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sacral Neuromodulation Device Market Size

The global market for Sacral Neuromodulation Device was valued at US$ 359 million in the year 2024 and is projected to reach a revised size of US$ 699 million by 2031, growing at a CAGR of 10.1% during the forecast period.

Sacral Neuromodulation Device Market

Sacral Neuromodulation Device Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Sacral Neuromodulation Device competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Sacral Neuromodulation Device is an implantable therapeutic system designed to deliver controlled electrical impulses to the sacral nerves in order to regulate neural signals involved in bladder, bowel, and pelvic floor function. The system typically includes an implantable pulse generator placed under the skin and one or more leads positioned near the sacral nerve roots. Through adjustable electrical stimulation, the device modulates abnormal nerve activity and helps restore functional control, offering sustained relief for patients with chronic pelvic or lower urinary tract disorders. Gross profit margins in the sacral neuromodulation device industry are typically between 60% and 80%.
The supply chain for Sacral Neuromodulation Devices begins with the procurement of medical-grade metals, advanced polymers, microprocessors, power cells, and biocompatible materials sourced from specialized component suppliers. Midstream processes involve precision manufacturing of leads, pulse generator assembly, software and firmware integration, and rigorous testing to ensure device reliability and adherence to global medical standards. Downstream activities include distribution through medical device suppliers and hospital networks, surgical implantation performed by trained specialists, and ongoing clinical support that covers device programming, follow-up care, and long-term patient monitoring. This integrated supply chain connects high-precision engineering with structured clinical workflows, ensuring safe and effective delivery of neuromodulation therapy.
The Sacral Neuromodulation Device market is strengthening as healthcare providers increasingly adopt neuromodulation as a long-term solution for urinary, bowel, and pelvic floor disorders that are difficult to manage with conventional treatments. Market expansion is supported by the growing demand for minimally invasive therapies, broader clinical acceptance, and continuous technological innovation that enhances device longevity, comfort, and programming flexibility. Manufacturers are competing on dimensions such as device size, battery performance, MRI access, and smart connectivity, while regulatory approvals and reimbursement improvements continue to shape regional growth patterns. As patient awareness increases and clinical outcomes demonstrate durable benefits, the market is positioned for steady advancement driven by product innovation and expanding global therapeutic adoption.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sacral Neuromodulation Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sacral Neuromodulation Device.
The Sacral Neuromodulation Device market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sacral Neuromodulation Device market comprehensively. Regional market sizes, concerning products by Type, by Application, by Clinical Indication and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sacral Neuromodulation Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Clinical Indication and by regions.

Scope of Sacral Neuromodulation Device Market Report

Report Metric Details
Report Name Sacral Neuromodulation Device Market
Accounted market size in year US$ 359 million
Forecasted market size in 2031 US$ 699 million
CAGR 10.1%
Base Year year
Forecasted years 2026 - 2031
Segment by Type
  • Rechargeable
  • Recharge-free
Segment by Clinical Indication
  • Urinary Dysfunction
  • Bowel Dysfunction
  • Chronic Pelvic Pain
  • Others
Segment by MRI Compatibility
  • MRI-conditional Stimulators
  • Non-MRI-compatible Stimulators
Segment by Application
  • Hospitals
  • ASCs
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Medtronic, Axonics (Boston Scientific), Neuspera, PINS Medical, General Stim (Nurotron)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Sacral Neuromodulation Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Sacral Neuromodulation Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Sacral Neuromodulation Device Market growing?

Ans: The Sacral Neuromodulation Device Market witnessing a CAGR of 10.1% during the forecast period 2026-2031.

What is the Sacral Neuromodulation Device Market size in 2031?

Ans: The Sacral Neuromodulation Device Market size in 2031 will be US$ 699 million.

Who are the main players in the Sacral Neuromodulation Device Market report?

Ans: The main players in the Sacral Neuromodulation Device Market are Medtronic, Axonics (Boston Scientific), Neuspera, PINS Medical, General Stim (Nurotron)

What are the Application segmentation covered in the Sacral Neuromodulation Device Market report?

Ans: The Applications covered in the Sacral Neuromodulation Device Market report are Hospitals, ASCs

What are the Type segmentation covered in the Sacral Neuromodulation Device Market report?

Ans: The Types covered in the Sacral Neuromodulation Device Market report are Rechargeable, Recharge-free

1 Sacral Neuromodulation Device Market Overview
1.1 Product Definition
1.2 Sacral Neuromodulation Device by Type
1.2.1 Global Sacral Neuromodulation Device Market Value Comparison by Type (2024 VS 2031)
1.2.2 Rechargeable
1.2.3 Recharge-free
1.3 Sacral Neuromodulation Device by Clinical Indication
1.3.1 Global Sacral Neuromodulation Device Market Value Comparison by Clinical Indication: 2024 VS 2031
1.3.2 Urinary Dysfunction
1.3.3 Bowel Dysfunction
1.3.4 Chronic Pelvic Pain
1.3.5 Others
1.4 Sacral Neuromodulation Device by MRI Compatibility
1.4.1 Global Sacral Neuromodulation Device Market Value Comparison by MRI Compatibility: 2024 VS 2031
1.4.2 MRI-conditional Stimulators
1.4.3 Non-MRI-compatible Stimulators
1.5 Sacral Neuromodulation Device by Application
1.5.1 Global Sacral Neuromodulation Device Market Value by Application (2024 VS 2031)
1.5.2 Hospitals
1.5.3 ASCs
1.6 Global Sacral Neuromodulation Device Market Size Estimates and Forecasts
1.6.1 Global Sacral Neuromodulation Device Revenue 2020-2031
1.6.2 Global Sacral Neuromodulation Device Sales 2020-2031
1.6.3 Global Sacral Neuromodulation Device Market Average Price (2020-2031)
1.7 Assumptions and Limitations
2 Sacral Neuromodulation Device Market Competition by Manufacturers
2.1 Global Sacral Neuromodulation Device Sales Market Share by Manufacturers (2020-2025)
2.2 Global Sacral Neuromodulation Device Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Sacral Neuromodulation Device Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Sacral Neuromodulation Device, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sacral Neuromodulation Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sacral Neuromodulation Device, Product Type & Application
2.7 Global Key Manufacturers of Sacral Neuromodulation Device, Date of Enter into This Industry
2.8 Global Sacral Neuromodulation Device Market Competitive Situation and Trends
2.8.1 Global Sacral Neuromodulation Device Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Sacral Neuromodulation Device Players Market Share by Revenue
2.8.3 Global Sacral Neuromodulation Device Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sacral Neuromodulation Device Market Scenario by Region
3.1 Global Sacral Neuromodulation Device Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Sacral Neuromodulation Device Sales by Region: 2020-2031
3.2.1 Global Sacral Neuromodulation Device Sales by Region: 2020-2025
3.2.2 Global Sacral Neuromodulation Device Sales by Region: 2026-2031
3.3 Global Sacral Neuromodulation Device Revenue by Region: 2020-2031
3.3.1 Global Sacral Neuromodulation Device Revenue by Region: 2020-2025
3.3.2 Global Sacral Neuromodulation Device Revenue by Region: 2026-2031
3.4 North America Sacral Neuromodulation Device Market Facts & Figures by Country
3.4.1 North America Sacral Neuromodulation Device Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Sacral Neuromodulation Device Sales by Country (2020-2031)
3.4.3 North America Sacral Neuromodulation Device Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sacral Neuromodulation Device Market Facts & Figures by Country
3.5.1 Europe Sacral Neuromodulation Device Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Sacral Neuromodulation Device Sales by Country (2020-2031)
3.5.3 Europe Sacral Neuromodulation Device Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sacral Neuromodulation Device Market Facts & Figures by Region
3.6.1 Asia Pacific Sacral Neuromodulation Device Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Sacral Neuromodulation Device Sales by Region (2020-2031)
3.6.3 Asia Pacific Sacral Neuromodulation Device Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Sacral Neuromodulation Device Market Facts & Figures by Country
3.7.1 Latin America Sacral Neuromodulation Device Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Sacral Neuromodulation Device Sales by Country (2020-2031)
3.7.3 Latin America Sacral Neuromodulation Device Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sacral Neuromodulation Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Sacral Neuromodulation Device Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Sacral Neuromodulation Device Sales by Country (2020-2031)
3.8.3 Middle East and Africa Sacral Neuromodulation Device Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sacral Neuromodulation Device Sales by Type (2020-2031)
4.1.1 Global Sacral Neuromodulation Device Sales by Type (2020-2025)
4.1.2 Global Sacral Neuromodulation Device Sales by Type (2026-2031)
4.1.3 Global Sacral Neuromodulation Device Sales Market Share by Type (2020-2031)
4.2 Global Sacral Neuromodulation Device Revenue by Type (2020-2031)
4.2.1 Global Sacral Neuromodulation Device Revenue by Type (2020-2025)
4.2.2 Global Sacral Neuromodulation Device Revenue by Type (2026-2031)
4.2.3 Global Sacral Neuromodulation Device Revenue Market Share by Type (2020-2031)
4.3 Global Sacral Neuromodulation Device Price by Type (2020-2031)
5 Segment by Application
5.1 Global Sacral Neuromodulation Device Sales by Application (2020-2031)
5.1.1 Global Sacral Neuromodulation Device Sales by Application (2020-2025)
5.1.2 Global Sacral Neuromodulation Device Sales by Application (2026-2031)
5.1.3 Global Sacral Neuromodulation Device Sales Market Share by Application (2020-2031)
5.2 Global Sacral Neuromodulation Device Revenue by Application (2020-2031)
5.2.1 Global Sacral Neuromodulation Device Revenue by Application (2020-2025)
5.2.2 Global Sacral Neuromodulation Device Revenue by Application (2026-2031)
5.2.3 Global Sacral Neuromodulation Device Revenue Market Share by Application (2020-2031)
5.3 Global Sacral Neuromodulation Device Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Sacral Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Medtronic Sacral Neuromodulation Device Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Axonics (Boston Scientific)
6.2.1 Axonics (Boston Scientific) Company Information
6.2.2 Axonics (Boston Scientific) Description and Business Overview
6.2.3 Axonics (Boston Scientific) Sacral Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Axonics (Boston Scientific) Sacral Neuromodulation Device Product Portfolio
6.2.5 Axonics (Boston Scientific) Recent Developments/Updates
6.3 Neuspera
6.3.1 Neuspera Company Information
6.3.2 Neuspera Description and Business Overview
6.3.3 Neuspera Sacral Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Neuspera Sacral Neuromodulation Device Product Portfolio
6.3.5 Neuspera Recent Developments/Updates
6.4 PINS Medical
6.4.1 PINS Medical Company Information
6.4.2 PINS Medical Description and Business Overview
6.4.3 PINS Medical Sacral Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.4.4 PINS Medical Sacral Neuromodulation Device Product Portfolio
6.4.5 PINS Medical Recent Developments/Updates
6.5 General Stim (Nurotron)
6.5.1 General Stim (Nurotron) Company Information
6.5.2 General Stim (Nurotron) Description and Business Overview
6.5.3 General Stim (Nurotron) Sacral Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.5.4 General Stim (Nurotron) Sacral Neuromodulation Device Product Portfolio
6.5.5 General Stim (Nurotron) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sacral Neuromodulation Device Industry Chain Analysis
7.2 Sacral Neuromodulation Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sacral Neuromodulation Device Production Mode & Process Analysis
7.4 Sacral Neuromodulation Device Sales and Marketing
7.4.1 Sacral Neuromodulation Device Sales Channels
7.4.2 Sacral Neuromodulation Device Distributors
7.5 Sacral Neuromodulation Device Customer Analysis
8 Sacral Neuromodulation Device Market Dynamics
8.1 Sacral Neuromodulation Device Industry Trends
8.2 Sacral Neuromodulation Device Market Drivers
8.3 Sacral Neuromodulation Device Market Challenges
8.4 Sacral Neuromodulation Device Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Sacral Neuromodulation Device Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Sacral Neuromodulation Device Market Value by Clinical Indication, (US$ Million) & (2024 VS 2031)
 Table 3. Global Sacral Neuromodulation Device Market Value by MRI Compatibility, (US$ Million) & (2024 VS 2031)
 Table 4. Global Sacral Neuromodulation Device Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 5. Global Sacral Neuromodulation Device Market Competitive Situation by Manufacturers in 2024
 Table 6. Global Sacral Neuromodulation Device Sales (Units) of Key Manufacturers (2020-2025)
 Table 7. Global Sacral Neuromodulation Device Sales Market Share by Manufacturers (2020-2025)
 Table 8. Global Sacral Neuromodulation Device Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 9. Global Sacral Neuromodulation Device Revenue Share by Manufacturers (2020-2025)
 Table 10. Global Market Sacral Neuromodulation Device Average Price (K US$/Unit) of Key Manufacturers (2020-2025)
 Table 11. Global Key Players of Sacral Neuromodulation Device, Industry Ranking, 2022 VS 2023 VS 2024
 Table 12. Global Key Manufacturers of Sacral Neuromodulation Device, Manufacturing Sites & Headquarters
 Table 13. Global Key Manufacturers of Sacral Neuromodulation Device, Product Type & Application
 Table 14. Global Key Manufacturers of Sacral Neuromodulation Device, Date of Enter into This Industry
 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 16. Global Sacral Neuromodulation Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sacral Neuromodulation Device as of 2024)
 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 18. Global Sacral Neuromodulation Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 19. Global Sacral Neuromodulation Device Sales by Region (2020-2025) & (Units)
 Table 20. Global Sacral Neuromodulation Device Sales Market Share by Region (2020-2025)
 Table 21. Global Sacral Neuromodulation Device Sales by Region (2026-2031) & (Units)
 Table 22. Global Sacral Neuromodulation Device Sales Market Share by Region (2026-2031)
 Table 23. Global Sacral Neuromodulation Device Revenue by Region (2020-2025) & (US$ Million)
 Table 24. Global Sacral Neuromodulation Device Revenue Market Share by Region (2020-2025)
 Table 25. Global Sacral Neuromodulation Device Revenue by Region (2026-2031) & (US$ Million)
 Table 26. Global Sacral Neuromodulation Device Revenue Market Share by Region (2026-2031)
 Table 27. North America Sacral Neuromodulation Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. North America Sacral Neuromodulation Device Sales by Country (2020-2025) & (Units)
 Table 29. North America Sacral Neuromodulation Device Sales by Country (2026-2031) & (Units)
 Table 30. North America Sacral Neuromodulation Device Revenue by Country (2020-2025) & (US$ Million)
 Table 31. North America Sacral Neuromodulation Device Revenue by Country (2026-2031) & (US$ Million)
 Table 32. Europe Sacral Neuromodulation Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 33. Europe Sacral Neuromodulation Device Sales by Country (2020-2025) & (Units)
 Table 34. Europe Sacral Neuromodulation Device Sales by Country (2026-2031) & (Units)
 Table 35. Europe Sacral Neuromodulation Device Revenue by Country (2020-2025) & (US$ Million)
 Table 36. Europe Sacral Neuromodulation Device Revenue by Country (2026-2031) & (US$ Million)
 Table 37. Asia Pacific Sacral Neuromodulation Device Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 38. Asia Pacific Sacral Neuromodulation Device Sales by Region (2020-2025) & (Units)
 Table 39. Asia Pacific Sacral Neuromodulation Device Sales by Region (2026-2031) & (Units)
 Table 40. Asia Pacific Sacral Neuromodulation Device Revenue by Region (2020-2025) & (US$ Million)
 Table 41. Asia Pacific Sacral Neuromodulation Device Revenue by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Sacral Neuromodulation Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Latin America Sacral Neuromodulation Device Sales by Country (2020-2025) & (Units)
 Table 44. Latin America Sacral Neuromodulation Device Sales by Country (2026-2031) & (Units)
 Table 45. Latin America Sacral Neuromodulation Device Revenue by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Sacral Neuromodulation Device Revenue by Country (2026-2031) & (US$ Million)
 Table 47. Middle East and Africa Sacral Neuromodulation Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 48. Middle East and Africa Sacral Neuromodulation Device Sales by Country (2020-2025) & (Units)
 Table 49. Middle East and Africa Sacral Neuromodulation Device Sales by Country (2026-2031) & (Units)
 Table 50. Middle East and Africa Sacral Neuromodulation Device Revenue by Country (2020-2025) & (US$ Million)
 Table 51. Middle East and Africa Sacral Neuromodulation Device Revenue by Country (2026-2031) & (US$ Million)
 Table 52. Global Sacral Neuromodulation Device Sales (Units) by Type (2020-2025)
 Table 53. Global Sacral Neuromodulation Device Sales (Units) by Type (2026-2031)
 Table 54. Global Sacral Neuromodulation Device Sales Market Share by Type (2020-2025)
 Table 55. Global Sacral Neuromodulation Device Sales Market Share by Type (2026-2031)
 Table 56. Global Sacral Neuromodulation Device Revenue (US$ Million) by Type (2020-2025)
 Table 57. Global Sacral Neuromodulation Device Revenue (US$ Million) by Type (2026-2031)
 Table 58. Global Sacral Neuromodulation Device Revenue Market Share by Type (2020-2025)
 Table 59. Global Sacral Neuromodulation Device Revenue Market Share by Type (2026-2031)
 Table 60. Global Sacral Neuromodulation Device Price (K US$/Unit) by Type (2020-2025)
 Table 61. Global Sacral Neuromodulation Device Price (K US$/Unit) by Type (2026-2031)
 Table 62. Global Sacral Neuromodulation Device Sales (Units) by Application (2020-2025)
 Table 63. Global Sacral Neuromodulation Device Sales (Units) by Application (2026-2031)
 Table 64. Global Sacral Neuromodulation Device Sales Market Share by Application (2020-2025)
 Table 65. Global Sacral Neuromodulation Device Sales Market Share by Application (2026-2031)
 Table 66. Global Sacral Neuromodulation Device Revenue (US$ Million) by Application (2020-2025)
 Table 67. Global Sacral Neuromodulation Device Revenue (US$ Million) by Application (2026-2031)
 Table 68. Global Sacral Neuromodulation Device Revenue Market Share by Application (2020-2025)
 Table 69. Global Sacral Neuromodulation Device Revenue Market Share by Application (2026-2031)
 Table 70. Global Sacral Neuromodulation Device Price (K US$/Unit) by Application (2020-2025)
 Table 71. Global Sacral Neuromodulation Device Price (K US$/Unit) by Application (2026-2031)
 Table 72. Medtronic Company Information
 Table 73. Medtronic Description and Business Overview
 Table 74. Medtronic Sacral Neuromodulation Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 75. Medtronic Sacral Neuromodulation Device Product
 Table 76. Medtronic Recent Developments/Updates
 Table 77. Axonics (Boston Scientific) Company Information
 Table 78. Axonics (Boston Scientific) Description and Business Overview
 Table 79. Axonics (Boston Scientific) Sacral Neuromodulation Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 80. Axonics (Boston Scientific) Sacral Neuromodulation Device Product
 Table 81. Axonics (Boston Scientific) Recent Developments/Updates
 Table 82. Neuspera Company Information
 Table 83. Neuspera Description and Business Overview
 Table 84. Neuspera Sacral Neuromodulation Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 85. Neuspera Sacral Neuromodulation Device Product
 Table 86. Neuspera Recent Developments/Updates
 Table 87. PINS Medical Company Information
 Table 88. PINS Medical Description and Business Overview
 Table 89. PINS Medical Sacral Neuromodulation Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 90. PINS Medical Sacral Neuromodulation Device Product
 Table 91. PINS Medical Recent Developments/Updates
 Table 92. General Stim (Nurotron) Company Information
 Table 93. General Stim (Nurotron) Description and Business Overview
 Table 94. General Stim (Nurotron) Sacral Neuromodulation Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 95. General Stim (Nurotron) Sacral Neuromodulation Device Product
 Table 96. General Stim (Nurotron) Recent Developments/Updates
 Table 97. Key Raw Materials Lists
 Table 98. Raw Materials Key Suppliers Lists
 Table 99. Sacral Neuromodulation Device Distributors List
 Table 100. Sacral Neuromodulation Device Customers List
 Table 101. Sacral Neuromodulation Device Market Trends
 Table 102. Sacral Neuromodulation Device Market Drivers
 Table 103. Sacral Neuromodulation Device Market Challenges
 Table 104. Sacral Neuromodulation Device Market Restraints
 Table 105. Research Programs/Design for This Report
 Table 106. Key Data Information from Secondary Sources
 Table 107. Key Data Information from Primary Sources
 Table 108. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Sacral Neuromodulation Device
 Figure 2. Global Sacral Neuromodulation Device Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Sacral Neuromodulation Device Market Share by Type: 2024 & 2031
 Figure 4. Rechargeable Product Picture
 Figure 5. Recharge-free Product Picture
 Figure 6. Global Sacral Neuromodulation Device Market Value by Clinical Indication, (US$ Million) & (2020-2031)
 Figure 7. Global Sacral Neuromodulation Device Market Share by Clinical Indication: 2024 VS 2031
 Figure 8. Urinary Dysfunction Product Picture
 Figure 9. Bowel Dysfunction Product Picture
 Figure 10. Chronic Pelvic Pain Product Picture
 Figure 11. Others Product Picture
 Figure 12. Global Sacral Neuromodulation Device Market Value by MRI Compatibility, (US$ Million) & (2020-2031)
 Figure 13. Global Sacral Neuromodulation Device Market Share by MRI Compatibility: 2024 VS 2031
 Figure 14. MRI-conditional Stimulators Product Picture
 Figure 15. Non-MRI-compatible Stimulators Product Picture
 Figure 16. Global Sacral Neuromodulation Device Market Value by Application (2020-2031) & (US$ Million)
 Figure 17. Global Sacral Neuromodulation Device Market Share by Application: 2024 & 2031
 Figure 18. Hospitals
 Figure 19. ASCs
 Figure 20. Global Sacral Neuromodulation Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 21. Global Sacral Neuromodulation Device Market Size (2020-2031) & (US$ Million)
 Figure 22. Global Sacral Neuromodulation Device Sales (2020-2031) & (Units)
 Figure 23. Global Sacral Neuromodulation Device Average Price (K US$/Unit) & (2020-2031)
 Figure 24. Sacral Neuromodulation Device Report Years Considered
 Figure 25. Sacral Neuromodulation Device Sales Share by Manufacturers in 2024
 Figure 26. Global Sacral Neuromodulation Device Revenue Share by Manufacturers in 2024
 Figure 27. Global 5 and 10 Largest Sacral Neuromodulation Device Players: Market Share by Revenue in Sacral Neuromodulation Device in 2024
 Figure 28. Sacral Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 29. Global Sacral Neuromodulation Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 30. North America Sacral Neuromodulation Device Sales Market Share by Country (2020-2031)
 Figure 31. North America Sacral Neuromodulation Device Revenue Market Share by Country (2020-2031)
 Figure 32. United States Sacral Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Canada Sacral Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Europe Sacral Neuromodulation Device Sales Market Share by Country (2020-2031)
 Figure 35. Europe Sacral Neuromodulation Device Revenue Market Share by Country (2020-2031)
 Figure 36. Germany Sacral Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. France Sacral Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. U.K. Sacral Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Italy Sacral Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Russia Sacral Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Asia Pacific Sacral Neuromodulation Device Sales Market Share by Region (2020-2031)
 Figure 42. Asia Pacific Sacral Neuromodulation Device Revenue Market Share by Region (2020-2031)
 Figure 43. China Sacral Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Japan Sacral Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. South Korea Sacral Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. India Sacral Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Australia Sacral Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. China Taiwan Sacral Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Indonesia Sacral Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Thailand Sacral Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Malaysia Sacral Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Latin America Sacral Neuromodulation Device Sales Market Share by Country (2020-2031)
 Figure 53. Latin America Sacral Neuromodulation Device Revenue Market Share by Country (2020-2031)
 Figure 54. Mexico Sacral Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Brazil Sacral Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Argentina Sacral Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Middle East and Africa Sacral Neuromodulation Device Sales Market Share by Country (2020-2031)
 Figure 58. Middle East and Africa Sacral Neuromodulation Device Revenue Market Share by Country (2020-2031)
 Figure 59. Turkey Sacral Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. Saudi Arabia Sacral Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 61. UAE Sacral Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 62. Global Sales Market Share of Sacral Neuromodulation Device by Type (2020-2031)
 Figure 63. Global Revenue Market Share of Sacral Neuromodulation Device by Type (2020-2031)
 Figure 64. Global Sacral Neuromodulation Device Price (K US$/Unit) by Type (2020-2031)
 Figure 65. Global Sales Market Share of Sacral Neuromodulation Device by Application (2020-2031)
 Figure 66. Global Revenue Market Share of Sacral Neuromodulation Device by Application (2020-2031)
 Figure 67. Global Sacral Neuromodulation Device Price (K US$/Unit) by Application (2020-2031)
 Figure 68. Sacral Neuromodulation Device Value Chain
 Figure 69. Channels of Distribution (Direct Vs Distribution)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD